Hyperbaric Oxygen Therapy in Diabetics With Chronic Foot Ulcers and Improvement of Quality of Life
1 other identifier
interventional
38
0 countries
N/A
Brief Summary
This study evaluated the effect of hyperbaric oxygen therapy (HBOT) on wound healing, inflammation index, glycemic control, amputation rate, survival rate of tissue, bacterial wound cultures, and quality of life (QOL) in diabetic foot ulcer (DFU) patients with diabetes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for phase_1
Started Jun 2011
Typical duration for phase_1
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2013
CompletedFirst Submitted
Initial submission to the registry
December 25, 2014
CompletedFirst Posted
Study publicly available on registry
December 31, 2014
CompletedDecember 31, 2014
December 1, 2014
2 years
December 25, 2014
December 30, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
wound healing
The Wagner Ulcer Grade Classification System for wound physiological index
4 weeks
Secondary Outcomes (5)
inflammation index
4 weeks
amputation rate
4 weeks
survival rate of tissue in the affected limb
4 weeks
bacteriological wound cultures
4 weeks
glycemic control
4 weeks
Study Arms (2)
hyperbaric oxygen therapy
EXPERIMENTALThe experimental group received treatments in a hyperbaric chamber for 120-min per session, once per day, and five days per week for four consecutive weeks (20 treatment sessions).
Control
NO INTERVENTIONThe control group received only routine care.
Interventions
HBOT was carried out in a hyperbaric chamber for 120-min per session, five days a week for four consecutive weeks (20 treatment sessions).
Eligibility Criteria
You may qualify if:
- over 20 years of age
- a history of diabetes and a diagnosis of diabetic foot
- a wound classification of Grade 3 or below
- clear conscious and willing to participate in this study
- a signed consent form
You may not qualify if:
- less than 20 years of age, unwilling to participate
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Chen-Yu Chenlead
- I-Shou Universitycollaborator
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Chen-Yu Chen, Master
Chang Gung Memorial Hospital
Study Design
- Study Type
- interventional
- Phase
- phase 1
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Registered Nurse
Study Record Dates
First Submitted
December 25, 2014
First Posted
December 31, 2014
Study Start
June 1, 2011
Primary Completion
June 1, 2013
Study Completion
June 1, 2013
Last Updated
December 31, 2014
Record last verified: 2014-12